GREAT DEBATE 1 - AORTIC LEAFLET MODIFICATION

Monday, March 9, 2026

2:05 PM - 2:35 PM EST

Location: Lincoln

Moderator(s)

Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure information not submitted.
Stephanie Sellers, PhD

Assistant Professor
University of British Columbia
Vancouver, British Columbia, Canada

No relationships to disclose

Panel Discussant(s)

Isida Byku, MD

Associate Professor, Structural/Interventional Cardiology
Emory University Hospital

No relationships to disclose
Jeremiah P. Depta, MD, MPHS, MBA, FACC, FSCAI

Medical Director of the Cardiac Catheterization Laboratory and Structural heart Disease
Medical College of Wisconsin/Froedtert Hospital
Milwaukee, Wisconsin, United States

No relationships to disclose
Rim Halaby, MD

Interventional Cardiologist/Staff Clinician
National Institutes of Health/National Heart, Lung, and Blood Institute

Disclosure information not submitted.
Jaffar M. Khan, MD, PhD

Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Roslyn, New York, United States

Disclosure information not submitted.
Amar Krishnaswamy, MD

Section Head, Interventional Cardiology
Cleveland Clinic
Cleveland, Ohio, United States

No relationships to disclose
Hussam Suradi, MD

Cath lab director
Rush University Medical Center
chicago, Illinois, United States

No relationships to disclose

Disclosure(s):

Toby Rogers, MD, PhD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)

Stephanie Sellers, PhD: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); BDC Labs: Grant/Research Support (Ongoing); Corcym: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Excision Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Vivitro Labs: Grant/Research Support (Ongoing)

Isida Byku, MD: Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jeremiah P. Depta, MD, MPHS, MBA, FACC, FSCAI: Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)

Amar Krishnaswamy, MD: No financial relationships to disclose

Hussam Suradi, MD: No financial relationships to disclose